Natural Infection of Guinea Pigs Exposed to Patients with Highly Drug-resistant Tuberculosis
Overview
Pulmonary Medicine
Authors
Affiliations
A natural TB infection model using guinea pigs may provide useful information for investigating differences in transmission efficiency and establishment of active disease by clinical TB strains in a highly susceptible host under controlled environmental conditions. We sought to examine the capacity of naturally transmitted multidrug-resistant Mycobacterium tuberculosis to establish infection and produce active disease in guinea pigs. Guinea pigs were continuously exposed for 4 months to the exhaust air of a 6-bed multidrug-resistant tuberculosis inpatient hospital ward in South Africa. Serial tuberculin skin test reactions were measured to determine infection. All animals were subsequently evaluated for histologic disease progression at necropsy. Although 75% of the 362 exposed guinea pigs had positive skin test reactions [≥6 mm], only 12% had histopathologic evidence of active disease. Reversions (≥6 mm change) in skin test reactivity were seen in 22% of animals, exclusively among those with reactions of 6-13 mm. Only two of 86 guinea pigs with reversion had histological evidence of disease compared to 47% (31/66) of guinea pigs with large, non-reverting reactions. Immunosuppression of half the guinea pigs across all skin test categories did not significantly accelerate disease progression. In guinea pigs that reverted a skin test, a second positive reaction in 27 (33%) of them strongly suggested re-infection due to ongoing exposure. These results show that a large majority of guinea pigs naturally exposed to human-source strains of multidrug-resistant tuberculosis became infected, but that many resolved their infection and a large majority failed to progress to detectable disease.
Lyu J, Narum D, Baldwin S, Larsen S, Bai X, Griffith D Front Immunol. 2024; 15:1427559.
PMID: 39717773 PMC: 11663721. DOI: 10.3389/fimmu.2024.1427559.
Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye.
Bobba S, Khader S Trends Immunol. 2023; 44(9):712-723.
PMID: 37543504 PMC: 11170062. DOI: 10.1016/j.it.2023.07.003.
Ferrets as a model for tuberculosis transmission.
Gupta T, Somanna N, Rowe T, LaGatta M, Helms S, Owino S Front Cell Infect Microbiol. 2022; 12:873416.
PMID: 36051240 PMC: 9425069. DOI: 10.3389/fcimb.2022.873416.
Controlled Human Infection Models To Accelerate Vaccine Development.
Choy R, Louis Bourgeois A, Ockenhouse C, Walker R, Sheets R, Flores J Clin Microbiol Rev. 2022; 35(3):e0000821.
PMID: 35862754 PMC: 9491212. DOI: 10.1128/cmr.00008-21.
Lovey A, Verma S, Kaipilyawar V, Ribeiro-Rodrigues R, Husain S, Palaci M Nat Commun. 2022; 13(1):884.
PMID: 35173157 PMC: 8850437. DOI: 10.1038/s41467-022-28506-2.